» Articles » PMID: 12401751

Concomitance of Diabetic Retinopathy and Proteinuria Accelerates the Rate of Decline of Kidney Function in Type 2 Diabetic Patients

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2002 Oct 29
PMID 12401751
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the rate of progression of renal disease in proteinuric type 2 diabetic patients with and without retinopathy.

Research Design And Methods: Thirty-eight proteinuric type 2 diabetic patients with diabetic retinopathy and 27 without were enrolled in an observational study for the evaluation of rate of glomerular filtration rate (GFR) decline and followed up for a median period of 6 years. GFR was determined at least once per year, and blood pressure, glycated hemoglobin, and proteinuria were determined every 4 months.

Results: Although the two groups had comparable GFR, albuminuria, blood pressure, and HbA(1c) at entry of the study, the rate of decline of GFR was higher in type 2 diabetic patients with retinopathy (-6.5 +/- 4.4 ml/year) than in those without (-1.8 +/- 4.8 ml/year; P < 0.0001). Protein and albumin excretion rate increased significantly in patients with retinopathy, while they did not change in those without. Mean blood pressure between the two groups of patients were similar both at entry and during the follow-up, although the proportion of patients treated with at least two antihypertensive drugs was higher in patients with retinopathy. On a multiple regression analysis, only mean blood pressure and proteinuria were significant determinants of progression of renal disease in type 2 diabetic patients with retinopathy.

Conclusions: The rate of progression of renal disease in proteinuric type 2 diabetic patients with retinopathy is faster than that observed in those without retinopathy. The screening for retinopathy identifies patients at high risk for rapid deterioration of kidney function.

Citing Articles

Decline in eGFR and mortality among type II diabetic patients: a 3-year prospective cohort study from Palestine.

Jaber M, Sharabati A, Nofal K, Hassan M, Hamdan Z, Nazzal Z BMC Nephrol. 2025; 26(1):64.

PMID: 39930337 PMC: 11808952. DOI: 10.1186/s12882-025-03947-1.


Risk factors for rapid kidney function decline in diabetes patients.

Xing J, Huang L, Ren W, Mei X Ren Fail. 2024; 46(2):2398188.

PMID: 39258389 PMC: 11391878. DOI: 10.1080/0886022X.2024.2398188.


Characterization of the visually impaired patients with diabetes mellitus in Japan.

Sugihara Y, Takamura Y, Yamada Y, Morioka M, Gozawa M, Kato K J Diabetes Investig. 2024; 15(7):882-891.

PMID: 38534040 PMC: 11215670. DOI: 10.1111/jdi.14195.


Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms.

Ou S, Tsai M, Lee K, Tseng W, Yang C, Chen T BioData Min. 2023; 16(1):8.

PMID: 36899426 PMC: 10007785. DOI: 10.1186/s13040-023-00324-2.


Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.

Samsu N Biomed Res Int. 2021; 2021:1497449.

PMID: 34307650 PMC: 8285185. DOI: 10.1155/2021/1497449.